Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. META
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018

Amphastar Pharma (AMPH) Tops Q4 EPS by 2c

March 12, 2019 4:17 PM EDT

Amphastar Pharma (NASDAQ: AMPH) reported Q4 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $89.7 million versus the consensus estimate of $78.18 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

... More